Grifols (WBO:GRF) Margin of Safety % (DCF Earnings Based): -17.35% (As of Jun. 24, 2026)


WBO:GRF Grifols SA WBO:GRF
83 GF Score
Price €9.04
GF Value €11.06
! 6 Warning Signs
View Full Analysis

What is Grifols Margin of Safety % (DCF Earnings Based)?

Grifols WBO:GRF -0.09% 83 Margin of Safety % (DCF Earnings Based) is -17.35% as of Jun. 24, 2026. GuruFocus rates WBO:GRF with a GF Score™ of 83/100 and a GF Value™ of €11.06. The stock has 6 warning signs investors should review.

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2026-06-24), Grifols's Predictability Rank is 3.5-Stars. Grifols's intrinsic value calculated from the Discounted Earnings model is €7.70 and current share price is €9.036. Consequently,

Grifols's Margin of Safety % (DCF Earnings Based) using Discounted Earnings model is -17.35%.

WBO:GRF vs LLY, JNJ, ABBV: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - General subindustry, Grifols's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Grifols Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grifols's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Grifols's Margin of Safety % (DCF Earnings Based) falls into.


WBO:GRF
83GF Score
Grifols SA WBO:GRF
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Grifols Margin of Safety % (DCF Earnings Based) Calculation

Grifols's Margin of Safety % (DCF Earnings Based) for today is calculated as

Margin of Safety % (DCF Earnings Based)=(Intrinsic Value: DCF (Earnings Based)-Current Price)/Intrinsic Value: DCF (Earnings Based)
=(7.70-9.036)/7.70
=-17.35 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted Earnings model with default parameters. The calculation method is the same as Discounted Cash Flow model except earnings are used in the calculation instead of free cash flow.

What does a Margin of Safety % (DCF Earnings Based) of -17.35% mean?
Grifols (WBO:GRF) has a Margin of Safety % (DCF Earnings Based) of -17.35% as of Jun. 24, 2026. Margin of Safety % (DCF Earnings Based) is the percent difference between the current price and the intrinsic DCF Earnings price. View historical data on Grifols.
Is Grifols' Margin of Safety % (DCF Earnings Based) too high?
Grifols' current Margin of Safety % (DCF Earnings Based) is -17.35%. Overall, Grifols has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does Grifols' Margin of Safety % (DCF Earnings Based) compare to LLY and JNJ?
Grifols' Margin of Safety % (DCF Earnings Based) of -17.35% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Margin of Safety % (DCF Earnings Based) for a Drug Manufacturers company?
A good Margin of Safety % (DCF Earnings Based) depends on the Drug Manufacturers industry context. However, Margin of Safety % (DCF Earnings Based) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Margin of Safety % (DCF Earnings Based) mean?
A high Margin of Safety % (DCF Earnings Based) can signal that a stock is expensive relative to its fundamentals. Margin of Safety % (DCF Earnings Based) is the percent difference between the current price and the intrinsic DCF Earnings price. View historical data on Grifols. Grifols's current Margin of Safety % (DCF Earnings Based) is -17.35%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grifols stock overvalued right now?
Grifols (WBO:GRF) has a current Margin of Safety % (DCF Earnings Based) of -17.35%. The stock's GF Value™ is €11.06, compared to a current price of €9.04 — trading 18.3% below its estimated fair value. The current Margin of Safety % (DCF Earnings Based) is -17.35%. Grifols' overall GF Score™ is 83/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Margin of Safety % (DCF Earnings Based) calculated?
Margin of Safety % (DCF Earnings Based) is calculated from a company's financial statements. For Grifols (WBO:GRF), the current Margin of Safety % (DCF Earnings Based) is -17.35% as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Grifols (WBO:GRF) Overvalued in 2026?

Based on GuruFocus' analysis, Grifols stock appears to be undervalued. The current stock price of €9.04 is trading 18.3% below its estimated GF Value™ of €11.06.

Key valuation signals for WBO:GRF:

  • Margin of Safety % (DCF Earnings Based): -17.35%
  • GF Value™: €11.06 vs. price of €9.04 (18.3% below fair value)
  • GF Score™: 83/100 with 6 warning signs

No single metric tells the full story. See the WBO:GRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Grifols Business Description

Address Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.
83GF Score

Get the complete analysis for WBO:GRF

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€9.04
Price
€11.06
GF Value